Stay updated on Margetuximab Combo in Chinese HER2+ MBC Clinical Trial

Sign up to get notified when there's something new on the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Recruitment status updated to Active, not recruiting. Last update posted on 2023-08-22.
    Difference
    0.1%
    Check dated 2025-11-03T13:43:59.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Core content updated to inform users about funding-related operating status and current NIH Clinical Center openness; version updated from v3.1.0 to v3.2.0.
    Difference
    13%
    Check dated 2025-10-06T04:14:11.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T23:35:06.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link has been removed.
    Difference
    0.8%
    Check dated 2025-09-14T09:53:21.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page has updated the status of Zai Lab (Hong Kong), Ltd. to 'Unknown status' and revised the version number from v3.0.0 to v3.0.1.
    Difference
    5%
    Check dated 2025-09-07T07:47:51.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while removing specific details about states, cities, and previously listed location countries.
    Difference
    10%
    Check dated 2025-08-31T00:59:32.000Z thumbnail image

Stay in the know with updates to Margetuximab Combo in Chinese HER2+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page.